Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

C75

(Synonyms: C-75) Copy Product Info
🥰Excellent

Synonyms: C-75

Catalog No. T10657 Copy Product Info
Purity: 98.84%
🥰Excellent
C75 is a fatty acid synthase (FASN) inhibitor (IC50 = 35 μM in PC3 cells) with cell permeability and the ability to activate CPT1A. This compound possesses antitumor activity and is commonly used in cancer-related experimental research.
C75
Cas No. 218137-86-1
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$41In Stock-
2 mg$596-8 weeks6-8 weeks
5 mg$98In Stock-
10 mg$165In Stock-
25 mg$3326-8 weeks6-8 weeks
50 mg$5306-8 weeks6-8 weeks
100 mg$8406-8 weeks6-8 weeks
1 mL x 10 mM (in DMSO)$108-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.84%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
C75 is a fatty acid synthase (FASN) inhibitor (IC50 = 35 μM in PC3 cells) with cell permeability and the ability to activate CPT1A. This compound possesses antitumor activity and is commonly used in cancer-related experimental research.
Targets & IC50
MCF-7 cells:27.3 μM, Fibroblast:63.2 μM, SKBR3 cells:19.8 μM, MDA-MB-231 cells:43.8 μM, MIAPaCa2 cells:21.8 μM, LNCaP cells:50 μM, PC3 cells:35 μM, HCT116 cells:46.4 μM, OVCAR-3 cells:21.9 μM
In vitro
Methods: The in vitro activity of C75 was validated using HeLa and CaSki cells. Cells were pretreated with 50 μM C75 for 1 hour, followed by wound healing, Transwell migration/invasion, and tube formation assays.
Results: C75 significantly inhibited the migration, invasion, and lymphangiogenesis abilities of cervical cancer cells. [1]
In vivo
Methods: BALB/c nude mice were used to establish a cervical cancer lymph node metastasis model, with HeLa or CaSki cells inoculated into the footpad. C75 was administered via intraperitoneal injection at a dose of 10 mg/kg every other day for 2 weeks, with vehicle as control.
Results: C75 treatment significantly suppressed popliteal lymph node volume and metastasis rate, and reduced lymphatic vessel density at the tumor site. [1]
Methods: A 4T1 breast cancer-bearing Balb/c mouse model was used, with C75 administered via intraperitoneal injection at a dose of 10 mg/kg every 3 days for 17 consecutive days.
Results: C75 monotherapy mildly inhibited tumor growth, while combination with CYH33 synergistically enhanced antitumor efficacy, increased FFA levels in tumor tissue, promoted CD8⁺ T cell infiltration, and reduced M2 macrophages. [2]
SynonymsC-75
Chemical Properties
Molecular Weight254.32
FormulaC14H22O4
Cas No.218137-86-1
SmilesCCCCCCCCC1OC(=O)C(=C)C1C(O)=O
Relative Density.1.08 g/cm3 (Predicted)
Storage & Solubility Information
StorageStore at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 75.6 mg/mL (297.26 mM), Sonication is recommended.
In Vivo Formulation
0.5% CMC-Na: 5 mg/mL (19.66 mM), Suspension.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9321 mL19.6603 mL39.3205 mL196.6027 mL
5 mM0.7864 mL3.9321 mL7.8641 mL39.3205 mL
10 mM0.3932 mL1.9660 mL3.9321 mL19.6603 mL
20 mM0.1966 mL0.9830 mL1.9660 mL9.8301 mL
50 mM0.0786 mL0.3932 mL0.7864 mL3.9321 mL
100 mM0.0393 mL0.1966 mL0.3932 mL1.9660 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: C75 chemical structure | C75 in vivo | C75 in vitro | C75 formula | C75 molecular weight